- Compositions and methods for treating hemorrhagic virus infections and other disorders
-
Cytokine-receptor and cytokine antagonist-enriched blood-dervided compositions and methods of preparing and using the compositions are provided. Also provided are compositions and methods for the treatment or prevention of disorders, especially acute inflammatory disorders involving pathological responses of the immune system, such as viral hemorrhagic diseases, sepsis, rheumatoid arthritis and other autoimmune disorders, acute cardiovascular events, flare-ups and acute phases of multiple sclerosis, wasting disorders and other disorders involving deleterious expression of cytokines and other factors, including tumor necrosis factor (TNF) and interleukin-1 (IL-1) are provided.
- -
-
-
- Manufacture of 6-methylenetetracyclines
-
Methacycline (6-methylene-5-oxytetracycline) is prepared by halogenating oxytetracycline (5-hydroxytetracycline) to produce the 11a-halo-6,12-hemiketal, under conditions which form and maintain the product in the enolic form, reacting the hemiketal base with acid to produce the hemiketal acid salt, dehydrating the acid salt to form 11a-halo-6-methylene-5-oxytetracycline, and reducing the compound to the salt of 6-methylene-5-oxytetracycline. An improved method for producing the 6-methylenetetracycline base from the product salt is also disclosed. The process is applicable to the synthesis of 6-methylenetetracycline per se or other 6-methylenetetracyclines, as well as methacycline.
- -
-
-
